tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

LEGN Stock Latest News

Legend Biotech price target lowered to $80 from $82 at Morgan Stanley
The FlyLegend Biotech price target lowered to $80 from $82 at Morgan Stanley
12d ago
LEGN
Legend Biotech (LEGN) Blockbuster Fuels Expectation-beating Growth
PremiumMarket News
Legend Biotech (LEGN) Blockbuster Fuels Expectation-beating Growth
17d ago
LEGN
Legend Biotech’s Earnings Call: Growth and Expansion
PremiumCompany Announcements
Legend Biotech’s Earnings Call: Growth and Expansion
17d ago
LEGN
Strong Buy Rating for Legend Biotech Driven by Carvykti’s Exceptional Growth and Competitive Edge
PremiumRatings
Strong Buy Rating for Legend Biotech Driven by Carvykti’s Exceptional Growth and Competitive Edge
17d ago
LEGN
Legend Biotech’s Growth Potential: Buy Rating Backed by Manufacturing Expansion and Safety Enhancements
PremiumRatings
Legend Biotech’s Growth Potential: Buy Rating Backed by Manufacturing Expansion and Safety Enhancements
17d ago
LEGN
Legend Biotech: Strong Sales and Strategic Focus Drive Buy Rating
PremiumRatingsLegend Biotech: Strong Sales and Strategic Focus Drive Buy Rating
17d ago
LEGN
Legend Biotech’s Strong CARVYKTI Sales Outlook and Capacity Expansion Drive Buy Rating
Premium
Ratings
Legend Biotech’s Strong CARVYKTI Sales Outlook and Capacity Expansion Drive Buy Rating
17d ago
LEGN
Legend Biotech price target raised to $75 from $73 at H.C. Wainwright
Premium
The Fly
Legend Biotech price target raised to $75 from $73 at H.C. Wainwright
17d ago
LEGN
Legend Biotech’s Promising Growth Trajectory: Revenue Milestones and Strategic Initiatives Drive Future Success
PremiumRatings
Legend Biotech’s Promising Growth Trajectory: Revenue Milestones and Strategic Initiatives Drive Future Success
17d ago
LEGN
Legend Biotech’s 2024 Earnings Highlight CARVYKTI® Success
PremiumCompany Announcements
Legend Biotech’s 2024 Earnings Highlight CARVYKTI® Success
18d ago
LEGN
Legend Biotech’s 2024 Financial Success and Strategic Advances
PremiumCompany Announcements
Legend Biotech’s 2024 Financial Success and Strategic Advances
18d ago
6K
LEGN
Legend Biotech reports Q4 adjusted EPS (15c), consensus (38c)
PremiumThe Fly
Legend Biotech reports Q4 adjusted EPS (15c), consensus (38c)
18d ago
LEGN
Legend Biotech sees cash runway into 2Q26
PremiumThe FlyLegend Biotech sees cash runway into 2Q26
18d ago
LEGN
Legend Biotech Corporation (LEGN) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Legend Biotech Corporation (LEGN) Q4 Earnings Cheat Sheet
20d ago
LEGN
Positive Developments in Carvykti Therapy Propel Legend Biotech to ‘Buy’ Rating
Premium
Ratings
Positive Developments in Carvykti Therapy Propel Legend Biotech to ‘Buy’ Rating
1M ago
LEGN
Legend Biotech price target lowered to $84.28 from $92.97 at Goldman Sachs
PremiumThe Fly
Legend Biotech price target lowered to $84.28 from $92.97 at Goldman Sachs
2M ago
LEGN
Legend Biotech Reports Q4 CARVYKTI® Sales
PremiumCompany Announcements
Legend Biotech Reports Q4 CARVYKTI® Sales
2M ago
6K
LEGN
Legend Biotech Showcases CAR-T Therapy Success at J.P. Morgan Healthcare Conference
PremiumCompany Announcements
Legend Biotech Showcases CAR-T Therapy Success at J.P. Morgan Healthcare Conference
2M ago
6K
LEGN
Legend Biotech rumor highlighted in Betaville alert
PremiumThe Fly
Legend Biotech rumor highlighted in Betaville alert
3M ago
LEGN
Legend Biotech price target lowered to $84 from $86 at RBC Capital
PremiumThe FlyLegend Biotech price target lowered to $84 from $86 at RBC Capital
3M ago
LEGN
Piper lowers sales estimates for Legend Biotech’s Carvykti
Premium
The Fly
Piper lowers sales estimates for Legend Biotech’s Carvykti
3M ago
JNJ
LEGN
Legend Biotech Announces Employee Transition Agreement
Premium
Company Announcements
Legend Biotech Announces Employee Transition Agreement
3M ago
6K
LEGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >